Gilead Sciences Rg
GILD
USD
STOCK MARKET:
NMS
Closed
 
...
Large gap with delayed quotes
Last quote
07/16/2026 - 23:20:00
Bid
07/16/2026 - 21:59:59
Bid
Volume
Ask
07/16/2026 - 21:59:59
Ask
Volume
136.30
+4.60 ( +3.49% )
136.26
2,200
136.28
4,600
More information
Analysis by TheScreener
14.07.2026
Evaluation Positive  
Interest Very strong  
Sensibility Low  
Analysis date: 14.07.2026
Global Evaluation
  Positive
The stock is classified in the positive zone since 03.07.2026.
Interest
  Very strong
Four stars since 10.07.2026.
Earnings Rev Trend
  Positive
 
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 10.07.2026 at a price of 129.83.
Evaluation
  Undervalued
 
Based on its growth potential and our own criteria, we believe the share price is currently moderately undervalued.
MT Tech Trend
  Neutral
 
The stock is currently trading close to its dividend-adjusted forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded above its moving average since 03.07.2026.
4wk Rel Perf
  2.70%
 
The four-week dividend-adjusted overperformance versus SP500 is 2.70%.
Sensibility
  Low
The stock has been on the low-sensitivity level since 26.12.2025.
Bear Market Factor
  Low
On average, the stock has a tendency to minimize the drops in the index by -0.76%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 2.67%.
Mkt Cap in $bn
  163.14
With a market capitalization >$8bn, GILEAD SCIENCES is considered a large-cap stock.
G/PE Ratio
  2.55
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
  12.42
The estimated PE is for the year 2028.
LT Growth
  29.05%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
  22
Over the last seven weeks, an average of 22 analysts provided earnings per share estimates.
Dividend Yield
  2.56%
The twelve month estimated dividend yield represents 31.82% of earnings forecasts.
Beta
  39
For 1% of index variation, the stock varies on average by 0.39%.
Correlation
  0.18
Stock movements are totally independent of index variations.
Value at Risk
  10.72
The value at risk is estimated at USD 10.72. The risk is therefore 8.25%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  02.01.2002